India’s Cadila to produce up to 30
India’s Cadila Healthcare (CADI.NS) is aiming to triple monthly production of a COVID-19 vaccine
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
India’s Cadila Healthcare (CADI.NS) is aiming to triple monthly production of a COVID-19 vaccine
Leaders of the world's largest economies kicked off a global health summit on Friday,
In early 2020, as a new deadly coronavirus began spreading around the world, Pfizer
People in the world's leading economies remain overwhelmingly nervous about returning to life as
Waiving intellectual property rights for COVID-19 vaccines will not be enough to narrow the
Here's what you need to know about the coronavirus right now
The European Union wants AstraZeneca to deliver at least 120 million doses of its
Indian opposition leader Rahul Gandhi called for a nationwide lockdown as the country’s tally
India’s election officials on Sunday started counting votes in five states from elections held
All vaccination centres in India’s financial capital of Mumbai were shut for three days